$695 Million is the total value of Octagon Capital Advisors LP's 36 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS INC | $59,071,924 | -11.6% | 2,551,703 | 0.0% | 8.50% | -18.4% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $49,557,440 | -23.2% | 2,468,000 | 0.0% | 7.13% | -29.0% | |
| MRTX | MIRATI THERAPEUTICS INC | $27,885,000 | -17.9% | 750,000 | 0.0% | 4.01% | -24.2% | |
| TNDM | TANDEM DIABETES CARE INC | $19,286,867 | -9.7% | 474,929 | 0.0% | 2.78% | -16.5% | |
| AVTE | AEROVATE THERAPEUTICS INC | $12,539,931 | -31.2% | 621,712 | 0.0% | 1.80% | -36.4% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,594,931 | -22.6% | 499,996 | 0.0% | 1.24% | -28.5% | |
| XILIO THERAPEUTICS INC | $7,687,250 | +17.8% | 2,425,000 | 0.0% | 1.11% | +8.9% | ||
| GOSS | GOSSAMER BIO INC | $2,467,167 | -41.9% | 1,958,069 | 0.0% | 0.36% | -46.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 33.2% |
| ARCUS BIOSCIENCES INC | 12 | Q3 2023 | 18.1% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 10.1% |
| GOSSAMER BIO INC | 12 | Q3 2023 | 6.2% |
| 4D MOLECULAR THERAPEUTICS IN | 10 | Q1 2023 | 6.6% |
| BRIDGEBIO PHARMA INC | 10 | Q3 2023 | 6.6% |
| AVIDITY BIOSCIENCES INC | 10 | Q1 2023 | 3.8% |
| VERA THERAPEUTICS INC | 9 | Q2 2023 | 3.5% |
| DYNE THERAPEUTICS INC | 9 | Q3 2023 | 3.5% |
| STOKE THERAPEUTICS INC | 9 | Q2 2023 | 3.7% |
View Octagon Capital Advisors LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-05 |
| SC 13G | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-25 |
| 13F-HR | 2022-11-14 |
View Octagon Capital Advisors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.